NDC 50742-623 – Lamivudine
Lamivudine 150 mg/1 · Tablet · Oral
Product NDC50742-623
Product details
- Brand name
- Lamivudine
- Generic name
- Lamivudine
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA206974
- Marketed since
- February 1, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Lamivudine 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50742-623-60 | 60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60) | Feb 1, 2017 |
Other Lamivudine products
- 50742-624 Lamivudine 300 mg/1 · Tablet · Ingenus Pharmaceuticals, LLC
- 60687-720 Lamivudine 150 mg/1 · Tablet, Film Coated · American Health Packaging
- 60505-3252 Lamivudine 300 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3251 Lamivudine 150 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3250 Lamivudine 100 mg/1 · Tablet, Film Coated · Apotex Corp.
- 65862-026 Lamivudine 300 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 65862-025 Lamivudine 150 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 65862-055 Lamivudine 10 mg/mL · Solution · Aurobindo Pharma Limited
- 31722-001 Lamivudine 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-752 Lamivudine 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-753 Lamivudine 150 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-754 Lamivudine 300 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.